In 2018, there were 9.6 hospital admissions per 1000 inhabitants in Switzerland in connection with a substance-related disorder (main or secondary diagnosis). Compared to 2012, the trend is slightly upwards. The most frequent of these are due to alcohol (5.9 per 1000 inhabitants), followed by tobacco (2.0 per 1000 inhabitants). A dependence syndrome is by far the most frequent diagnosis for all substances. In total, as well as for almost every substance individually, significantly fewer hospital admissions in connection with substance-related disorders are recorded for women than for men. The exceptions are sedatives and hypnotics.

This indicator is part of the Monitoring System Addiction and NCD (MonAM) of the Federal Office of Public Health (FOPH).

The consumption of psychoactive substances can have harmful effects. One such negative impact is shown by this indicator - hospital admissions due to substance-related disorders. It incorporates a series of illegal (such as opioids and cannabinoids) and legal (such as alcohol and tobacco) substances.  The indicator also provides information (optional) on the type of disorder.

The strategy for addiction seeks to create a network bringing together medical and psychiatric service providers with those from the fields of social medicine and psychosocial care, founded on knowledge about the type and scope of treatment available in acute hospitals and psychiatric clinics.


This indicator is calculated using data from the Hospital Medical Statistics.

It shows the rate of hospital admissions due to substance-related disorders in somatic or psychiatric clinics per 1000 population. Data are standardised according to the age structure of the European standard population in 2010 (European Commission, 2013).

The total is comprised of all cases with a main or secondary diagnosis from the ICD-10 group F10-F19 (Mental and behavioural disorders due to psychoactive substances). The total takes account of all cases the main or secondary diagnosis of which is covered by ICD-10 codes F10–F19 (Mental and behavioural disorders due to psychoactive substance use). The diagram shows the total and the six most important categories, but no subdivision by substance. Patients were classified by the diagnosis recorded on discharge from hospital.

The following substances were included (ICD-10 classification): F10-F19):

  • Alcohol
  • Opioids
  • Cannabis
  • Sedatives or hypnotics
  • Cocaine
  • Other stimulants
  • Hallucinogens
  • Tobacco
  • Inhalants
  • Multiple substance use and other psychotropic substances

A break in the time series between 2011 and 2012 arose due to the implementation of the Health Insurance Act’s revision of hospital funding and the consequent new definition of a treatment case for services provided under SwissDRG. For this reason, only the years from 2012 onwards are shown.

Users should be aware of the change in the coding practice for secondary diagnoses, as described by Marmet et al., which may lead to an overestimate in the increase.



  • Marmet, S., et al. (2017). Hospitalisierungen aufgrund von Alkoholintoxikation oder Alkoholabhängigkeit bei Jugendlichen und Erwachsenen – Eine Analyse der Schweizerischen „Medizinischen Statistik der Krankenhäuser“ 2003 bis 2014 (Forschungsbericht Nr. 92). Sucht Schweiz, Lausanne: Report (in German)
  • Revision of the European Standard Population — Report of Eurostat's task force (2013). European Commission. Luxembourg: Publications Office of the European Union, p. 121: Report 

Media enquiries

Federal Office of Public Health FOPH
Tel. +41 58 462 95 05

Last updated